TriangleHEALTH PROFESSIONAL · SOURCE READING
Endobronchial therapies
Source: Non-Small Cell Lung Cancer Treatment (PDQ®)–Health Professional Version, National Cancer Institute.
Source updated: May 15, 2025 · Captured 2026-09-09.
Selected source text with whitespace normalised. This Triangle page is not an NCI PDQ summary.
Context: Treatment of Stage 0 NSCLC / Treatment Options for Stage 0 NSCLC
Patients with central lesions may be candidates for curative endobronchial therapy. Endobronchial therapies that preserve lung function include photodynamic therapy, electrocautery, cryotherapy, and Nd-YAG laser therapy.[3-6]
Evidence (endobronchial therapies):
Small case series have reported high complete response rates and long-term survival in selected patients.[7,8][Level of evidence C2]
Source links and citations
Efficacy of these treatment modalities in the management of patients with early NSCLC remains to be proven in definitive randomized controlled trials.
Publication references
Read the original reference and check its publication notices.
Preserved source evidence · Not medical advice